JPRN-UMIN000038250
尚未招募
3 期
Verification of safety and efficacy of early exercise therapy intervention for acute nephrotic syndrome - Nephrotic syndrome test
概览
- 阶段
- 3 期
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Hamamatsu University School of Medicine
- 入组人数
- 25
- 状态
- 尚未招募
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\.A person with a history of comorbid heart disease or pulmonary disease. 2\.Those who cannot perform tests such as muscle strength measurement or appropriate exercise therapy due to orthopedic disease. 3\.Those with unhealed cancer
结局指标
主要结局
未指定
相似试验
已完成
1 期
DCB-DM101 in Participants with Type 2 Diabetes MellitusACTRN12618001140246VitNovo Australia Pty Ltd24
招募中
1 期
A Phase I Study to Evaluate the Safety and Efficacy of Mesenchymal Stromal Cells (MSC) for Treating Chronic Obstructive Pulmonary Disease (COPD)COPDRespiratory - Chronic obstructive pulmonary diseaseACTRN12614000731695Royal Perth Hospital10
已完成
1 期
Phase 1 study to evaluate the safety and efficacy of jyuzentaihoto in infantile anal fistulainfantile anal fistulaJPRN-UMIN000021336Kanazawa University20
招募中
1 期
A Phase I/II study to assess the safety and efficacy of full-spectrum medicinal cannabis plant extract 0.08% THC (NTI164) in the treatment of Rett syndrome (RTT)Rett SyndromeNeurological - Neurodegenerative diseasesACTRN12623000563662Fenix Innovation Group14
终止
不适用
A phase I study to determine the efficacy and safety of CKD-516 tablet combined with durvalumab(MEDI4736) in patient refractory solid tumorsKCT0005756Asan Medical Center42